Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways

Area of Science:

• Biochemistry
• Cell Biology
• Bone Biology

Background:

• Melatonin exhibits diverse biological activities, including antioxidant and antiangiogenic properties.
• The precise molecular mechanisms underlying melatonin's effects on bone formation (osteogenesis) are not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanisms by which melatonin influences the differentiation of mouse osteoblastic MC3T3-E1 cells.
• To investigate melatonin's role in osteogenesis and identify the signaling pathways involved.

Main Methods:

• Utilized MC3T3-E1 cells, a common model for osteoblast differentiation.
• Assessed osteoblastic differentiation and mineralization.
• Measured the expression of key osteogenesis markers (Runx2, OCN, BMP-2, BMP-4).
• Investigated the activation of Wnt5α/β, β-catenin, JNK, ERK, and GSK-3β signaling pathways.
• Employed inhibitors (Noggin, PD98059) and confocal microscopy to validate pathway involvement.

Main Results:

• Melatonin significantly enhanced osteoblastic differentiation and mineralization in MC3T3-E1 cells.
• Melatonin upregulated osteogenesis markers, including Runx2, OCN, and BMPs.
• Melatonin activated the BMP/ERK/Wnt signaling cascade, evidenced by increased β-catenin nuclear localization and altered phosphorylation states of key kinases.
• Inhibitors confirmed the critical role of BMP and ERK signaling in mediating melatonin's effects on Wnt pathway activation.

Conclusions:

• Melatonin promotes osteoblastic differentiation and mineralization through the BMP/ERK/Wnt signaling pathways.
• These findings clarify the molecular basis of melatonin's osteogenic potential.
• Melatonin represents a potential therapeutic agent for bone-related disorders.